• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EZH2 在基底样乳腺癌细胞中促进双谱系特征。

EZH2 promotes a bi-lineage identity in basal-like breast cancer cells.

机构信息

Department of Developmental Biology and Cancer Research, Institute for Medical Research – Israel-Canada, Hadassah School of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

出版信息

Oncogene. 2013 Aug 15;32(33):3886-95. doi: 10.1038/onc.2012.390.

DOI:10.1038/onc.2012.390
PMID:22986524
Abstract

The mechanisms regulating breast cancer differentiation state are poorly understood. Of particular interest are molecular regulators controlling the highly aggressive and poorly differentiated traits of basal-like breast carcinomas. Here we show that the Polycomb factor EZH2 maintains the differentiation state of basal-like breast cancer cells, and promotes the expression of progenitor associated and basal-lineage genes. Specifically, EZH2 regulates the composition of basal-like breast cancer cell populations by promoting a ‘bi-lineage’ differentiation state, in which cells co-express basal- and luminal-lineage markers. We show that human basal-like breast cancers contain a subpopulation of bi-lineage cells, and that EZH2-deficient cells give rise to tumors with a decreased proportion of such cells. Bi-lineage cells express genes that are active in normal luminal progenitors, and possess increased colony-formation capacity, consistent with a primitive differentiation state. We found that GATA3, a driver of luminal differentiation, performs a function opposite to EZH2, acting to suppress bi-lineage identity and luminal-progenitor gene expression. GATA3 levels increase upon EZH2 silencing, mediating a decrease in bi-lineage cell numbers. Our findings reveal a novel role for EZH2 in controlling basal-like breast cancer differentiation state and intra-tumoral cell composition.

摘要

调控乳腺癌分化状态的机制尚不清楚。特别有趣的是,分子调控因子控制基底样乳腺癌的高度侵袭性和低分化特征。在这里,我们表明多梳抑制因子 EZH2 维持基底样乳腺癌细胞的分化状态,并促进祖细胞相关和基底谱系基因的表达。具体来说,EZH2 通过促进“双谱系”分化状态来调节基底样乳腺癌细胞群体的组成,其中细胞共同表达基底和腔系标记物。我们表明,人基底样乳腺癌包含一个双谱系细胞亚群,EZH2 缺陷细胞产生的肿瘤中这种细胞的比例降低。双谱系细胞表达在正常腔前体细胞中活跃的基因,并具有增加的集落形成能力,与原始分化状态一致。我们发现,GATA3 是腔分化的驱动因子,其功能与 EZH2 相反,可抑制双谱系特征和腔前体细胞基因的表达。EZH2 沉默后 GATA3 水平升高,导致双谱系细胞数量减少。我们的研究结果揭示了 EZH2 在控制基底样乳腺癌分化状态和肿瘤内细胞组成中的新作用。

相似文献

1
EZH2 promotes a bi-lineage identity in basal-like breast cancer cells.EZH2 在基底样乳腺癌细胞中促进双谱系特征。
Oncogene. 2013 Aug 15;32(33):3886-95. doi: 10.1038/onc.2012.390.
2
The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer.在基底样乳腺癌模型中,组蛋白甲基转移酶EZH2可促进乳腺干细胞和管腔祖细胞的扩增、转移,并抑制雌激素受体阳性细胞的分化。
Oncol Rep. 2015 Jul;34(1):455-60. doi: 10.3892/or.2015.4003. Epub 2015 May 21.
3
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.全球 H3K27 三甲基化和 EZH2 丰度在乳腺肿瘤亚型中的研究。
Mol Oncol. 2012 Oct;6(5):494-506. doi: 10.1016/j.molonc.2012.06.002. Epub 2012 Jun 20.
4
Repression of Igf1 expression by Ezh2 prevents basal cell differentiation in the developing lung.Ezh2对Igf1表达的抑制作用可阻止发育中的肺脏中基底细胞的分化。
Development. 2015 Apr 15;142(8):1458-69. doi: 10.1242/dev.122077. Epub 2015 Mar 19.
5
Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity.在缺乏基底样活性的情况下,肿瘤起始但分化的腔样乳腺癌细胞具有高度侵袭性。
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6124-9. doi: 10.1073/pnas.1203203109. Epub 2012 Mar 27.
6
Downregulation of Ezh2 methyltransferase by FOXP3: new insight of FOXP3 into chromatin remodeling?FOXP3对Ezh2甲基转移酶的下调作用:FOXP3对染色质重塑的新见解?
Biochim Biophys Acta. 2013 Oct;1833(10):2190-200. doi: 10.1016/j.bbamcr.2013.05.014. Epub 2013 May 17.
7
Polycomb group gene Ezh2 regulates mammary gland morphogenesis and maintains the luminal progenitor pool.多梳抑制复合物基因 Ezh2 调控乳腺形态发生并维持腔前体细胞库。
Stem Cells. 2013 Sep;31(9):1910-20. doi: 10.1002/stem.1437.
8
Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity.Ezh2通过组蛋白甲基转移酶活性调节自然杀伤细胞的分化和功能。
Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):15988-93. doi: 10.1073/pnas.1521740112. Epub 2015 Dec 14.
9
Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers.EZH2 通过调控 NF-κB 靶基因表达在乳腺癌中具有组织特异性。
Mol Cell. 2011 Sep 2;43(5):798-810. doi: 10.1016/j.molcel.2011.08.011.
10
Ezh2 represses the basal cell lineage during lung endoderm development.Ezh2在肺内胚层发育过程中抑制基底细胞谱系。
Development. 2015 Jan 1;142(1):108-17. doi: 10.1242/dev.116947.

引用本文的文献

1
Discovery of epigenetically silenced tumour suppressor genes in aggressive breast cancer through a computational approach.通过计算方法在侵袭性乳腺癌中发现表观遗传沉默的肿瘤抑制基因。
NAR Cancer. 2025 Jun 18;7(2):zcaf020. doi: 10.1093/narcan/zcaf020. eCollection 2025 Jun.
2
Drug-induced tolerant persisters in tumor: mechanism, vulnerability and perspective implication for clinical treatment.肿瘤中药物诱导的耐受性持久性细胞:机制、易损性及对临床治疗的潜在意义
Mol Cancer. 2025 May 24;24(1):150. doi: 10.1186/s12943-025-02323-9.
3
Fibrin Stiffness Regulates Phenotypic Plasticity of Metastatic Breast Cancer Cells.
纤维蛋白刚性调节转移性乳腺癌细胞的表型可塑性。
Adv Healthc Mater. 2023 Dec;12(31):e2301137. doi: 10.1002/adhm.202301137. Epub 2023 Sep 21.
4
TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis.TLE3 维持腔面乳腺癌谱系保真度以抑制转移。
Cancer Res. 2023 Apr 4;83(7):997-1015. doi: 10.1158/0008-5472.CAN-22-3133.
5
EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis.EZH2-H3K27me3 介导的 KRT14 上调促进三阴性乳腺癌腹膜转移。
Nat Commun. 2022 Nov 29;13(1):7344. doi: 10.1038/s41467-022-35059-x.
6
Tumor suppressor DEAR1 regulates mammary epithelial cell fate and predicts early onset and metastasis in triple negative breast cancer.抑癌基因 DEAR1 调控乳腺上皮细胞命运并预测三阴性乳腺癌的早期发病和转移。
Sci Rep. 2022 Nov 14;12(1):19504. doi: 10.1038/s41598-022-22417-4.
7
PAR-Induced Harnessing of EZH2 to β-Catenin: Implications for Colorectal Cancer.PAR 诱导的 EZH2 对 β-连环蛋白的利用:对结直肠癌的影响。
Int J Mol Sci. 2022 Aug 6;23(15):8758. doi: 10.3390/ijms23158758.
8
Polyploid giant cancer cells, EZH2 and Myc upregulation in mammary epithelial cells infected with high-risk human cytomegalovirus.高危型人巨细胞病毒感染乳腺上皮细胞中的多倍体巨大癌细胞、EZH2 和 Myc 上调。
EBioMedicine. 2022 Jun;80:104056. doi: 10.1016/j.ebiom.2022.104056. Epub 2022 May 18.
9
TET2 directs mammary luminal cell differentiation and endocrine response.TET2 指导乳腺腔细胞分化和内分泌反应。
Nat Commun. 2020 Sep 15;11(1):4642. doi: 10.1038/s41467-020-18129-w.
10
NF-κB/NKILA signaling modulates the anti-cancerous effects of EZH2 inhibition.NF-κB/NKILA 信号转导调节 EZH2 抑制的抗癌作用。
J Cell Mol Med. 2019 Sep;23(9):6182-6192. doi: 10.1111/jcmm.14500. Epub 2019 Jul 7.